Founded in 2012, ActX is the first company to make the everyday use of genomic information feasible for practicing physicians. ActX provides a complete solution that uses genetics to alert physicians about drug-genome interactions and actionable medical risks, directly in their Electronic Health Record. ActX enables a new era of precision medicine that will improve patient care.
The ActX Service is evidence based and focuses on actionable genetic risks, risk that the physician and patient can do something about. The ActX Service includes affordable, saliva based, genetic testing that leads to built-in alerts and a genomic risk profile display.
The ActX Service checks each prescription as it is written for possible adverse reactions, efficacy and dosing issues. ActX checks the patient for actionable genetic risks such as cancer and cardiovascular risks. For more information about ActX and taking the next step towards precision medicine, visit us at www.actx.com.